This Alzheimer’s Test Sounds...

🧪 “Everyone’s talking about the p-tau217 test for Alzheimer’s… but not so fast.” Dr....

World Vegan Day 2026:...

World Vegan Day, observed on November 1, highlights animal welfare,...

What Happens to Your...

Stopping exercise can affect heart health, aerobic fitness and muscle...
HomeVIDEOSReal-World Management of...

Real-World Management of Early Alzheimer’s Disease: Maintenance Therapy and Long-Term Evidence



Please visit www.answersincme.com/TZA860 to participate, download slides and supporting materials, complete the post-test, and get a certificate. Presented by James E. Galvin, MD, MPH. In this activity, an expert in Alzheimer’s disease (AD) discusses treatment of early AD with anti-amyloid therapies. Upon completion of this activity, participants should be better able to: Review the latest advances in anti-amyloid therapies for the treatment of early Alzheimer’s disease (AD). Assess the current evidence on anti-amyloid therapies, including maintenance strategies, for the treatment of early AD. Outline strategies to integrate the latest advances in anti-amyloid therapies to practice to improve long-term outcomes for patients with early AD.

source

Continue reading

Researchers test noninvasive ultrasound treatment for schizophrenia-related hallucinations

Auditory hallucinations – or hearing voices that others do not hear – affect more than 70% of people with schizophrenia. Despite treatment with antipsychotic medications, approximately...

This Alzheimer’s Test Sounds Amazing… But Here’s What No One’s Telling You about the p-Tau217 test

🧪 “Everyone’s talking about the p-tau217 test for Alzheimer’s… but not so fast.” Dr. Richard Isaacson sits down with @maxlugavere to break down the hype—and the reality—behind blood tests for Alzheimer’s, like p-tau217. source

World Vegan Day 2026: Health Benefits and Nutritional Risks of Going Vegan

World Vegan Day, observed on November 1, highlights animal welfare, environmental sustainability and plant-based nutrition.